Coagulation abnormalities and cardiovascular disease

    Research output: Contribution to journalReview articlepeer-review

    18 Scopus citations


    In patients with excessive venous thrombosis, genetic defects predisposing to thrombosis can be found in 60-80%. Increased plasma levels of coagulation proteins such as fibrinogen and plasminogen activator inhibitor-1 (PAI-1) are associated with an increased risk of myocardial infarction. However, despite the presence of polymorphisms that regulate plasma levels of factor VIII, PAI-1, and fibrinogen the association between common polymorphisms of these coagulation protein and ischemic cardiac disease remains ambiguous. Up to 10% of the population have defects that predispose them to excessive venous thrombosis. In spite of the essential role of thrombosis in coronary ischemic syndrome, no convincing evidence has implicated the two most common venous hypercoagulable states in ischemic heart disease. Pathogenic polymorphisms in the platelet fibrinogen and collagen receptors remain an area of intense research interest. Finally, it has been shown that lipoproteins can act as mediators of coagulation processes.

    Original languageEnglish (US)
    Pages (from-to)443-448
    Number of pages6
    JournalCurrent opinion in lipidology
    Issue number5
    StatePublished - Dec 1 1999

    ASJC Scopus subject areas

    • Endocrinology, Diabetes and Metabolism
    • Molecular Biology
    • Genetics
    • Nutrition and Dietetics
    • Cardiology and Cardiovascular Medicine
    • Cell Biology


    Dive into the research topics of 'Coagulation abnormalities and cardiovascular disease'. Together they form a unique fingerprint.

    Cite this